Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:24 PM
Ignite Modification Date:
2025-12-24 @ 12:24 PM
NCT ID:
NCT01895361
Eligibility Criteria:
Key Inclusion Criteria:
* Sickle Cell Disease (HbSS, HbSC, HbSβ⁰-thalassemia, or HbSβ⁺-thalassemia)
* If receiving hydroxyurea or erythropoietin, treatment must have been prescribed for at least 6 months, with the dose stable for at least 3 months
* Between 2 and 10 sickle cell-related pain crises in the past 12 months
Key Exclusion Criteria:
* On a chronic transfusion program or planning on exchange transfusion during the study
* Hemoglobin \<4.0 g/dL
* Planned initiation, termination, or dose alteration of hydroxyurea during the study
* Receiving chronic anticoagulation therapy (e.g. warfarin, heparin) other than aspirin
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
16 Years
Maximum Age:
65 Years
Study:
NCT01895361
Study Brief:
Protocol Section:
NCT01895361